# IQVIA (United Kingdom)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/iqvia-united-kingdom/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 25.3 |
| Citations | 126,306 |
| City | London |
| Country | GB |
| Description | IQVIA (United Kingdom) is a research organisation in London, GB. OpenAlex records 4,022 works and 126,306 citations for it. 1,830 researchers list it as their most recent affiliation. |
| Homepage | https://www.iqvia.com/ |
| OpenAlex ID | https://openalex.org/I28927889 |
| Researchers | 1,830 |
| ROR ID | https://ror.org/040g76k92 |
| Type | company |
| Wikidata ID | https://www.wikidata.org/wiki/Q305473 |
| Works | 4,022 |

## University papers

Showing 12 of 32.

- [Life expectancy at birth in Duchenne muscular dystrophy: a systematic review and meta-analysis](https://scholariq.org/papers/life-expectancy-at-birth-in-duchenne-muscular-dystrophy-a-systematic-review-and/)
- [The burden of Duchenne muscular dystrophy](https://scholariq.org/papers/the-burden-of-duchenne-muscular-dystrophy/)
- [The contribution of musculoskeletal disorders in multimorbidity: Implications for practice and policy](https://scholariq.org/papers/the-contribution-of-musculoskeletal-disorders-in-multimorbidity-implications-for/)
- [The prevalence of depression in axial spondyloarthritis and its association with disease activity: a systematic review and meta-analysis](https://scholariq.org/papers/the-prevalence-of-depression-in-axial-spondyloarthritis-and-its-association-with/)
- [Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis](https://scholariq.org/papers/concomitant-fibromyalgia-complicating-chronic-inflammatory-arthritis-a/)
- [The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis](https://scholariq.org/papers/the-prevalence-and-impact-of-comorbid-fibromyalgia-in-inflammatory-arthritis/)
- [Quantifying the burden of caregiving in Duchenne muscular dystrophy](https://scholariq.org/papers/quantifying-the-burden-of-caregiving-in-duchenne-muscular-dystrophy/)
- [The impact of the COVID-19 pandemic on cardiovascular disease prevention and management](https://scholariq.org/papers/the-impact-of-the-covid-19-pandemic-on-cardiovascular-disease-prevention-and/)
- [Duchenne muscular dystrophy and caregiver burden: a systematic review](https://scholariq.org/papers/duchenne-muscular-dystrophy-and-caregiver-burden-a-systematic-review/)
- [Adherence to treatment of primary osteoporosis and its association to fractures—the Swedish Adherence Register Analysis (SARA)](https://scholariq.org/papers/adherence-to-treatment-of-primary-osteoporosis-and-its-association-to-fractures/)
- [Health‐related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross‐sectional study](https://scholariq.org/papers/health-related-quality-of-life-in-patients-with-duchenne-muscular-dystrophy-a/)
- [Systematic review of mental health comorbidities in psoriatic arthritis](https://scholariq.org/papers/systematic-review-of-mental-health-comorbidities-in-psoriatic-arthritis/)

## University researchers

- [Erik Landfeldt](https://scholariq.org/researchers/erik-landfeldt/)
- [Stephen Duffield](https://scholariq.org/researchers/stephen-duffield/)
- [Vita Dikariyanto](https://scholariq.org/researchers/vita-dikariyanto/)

## University top topics

Showing 8 of 25.

- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)
- [Statistical Methods in Clinical Trials](https://scholariq.org/topics/statistical-methods-in-clinical-trials/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Asthma and respiratory diseases](https://scholariq.org/topics/asthma-and-respiratory-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
